HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adam P Boyd Selected Research

NTLA-2001

1/2021CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adam P Boyd Research Topics

Disease

3Neoplasms (Cancer)
11/2020 - 01/2006
2Neoplasm Metastasis (Metastasis)
03/2006 - 01/2006
2Brain Neoplasms (Brain Tumor)
03/2006 - 01/2006
2Hypoxia (Hypoxemia)
01/2006 - 09/2005
1Transthyretin-Related Hereditary Amyloidosis
01/2021
1Amyloidosis
01/2021
1Polyneuropathies (Polyneuropathy)
01/2021
1Ovarian Neoplasms (Ovarian Cancer)
11/2020
1Carcinoma (Carcinomatosis)
11/2020
1Breast Neoplasms (Breast Cancer)
01/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2005
1Radiation Pneumonitis
09/2005
1Fatigue
09/2005

Drug/Important Bio-Agent (IBA)

3efaproxiral (RSR-13)IBA
03/2006 - 09/2005
2Oxygen (Dioxygen)IBA
03/2006 - 01/2006
2Hemoglobins (Hemoglobin)IBA
03/2006 - 01/2006
1NTLA-2001IBA
01/2021
1Prealbumin (Transthyretin)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1binimetinibIBA
11/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020
1Radiation-Sensitizing AgentsIBA
01/2006

Therapy/Procedure

3Radiotherapy
03/2006 - 09/2005
1Drug Therapy (Chemotherapy)
11/2020
1Induction Chemotherapy
09/2005